ArticleBMC psychiatry2025
Correlations of oxidative stress markers with niacin sensitivity in male patients with chronic schizophrenia.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The interplay of niacin skin flush response with plasma MDA, TNOS, iNOS and clinical symptom severity in chronic schizophrenia.BMC psychiatry · 2026Article
- Interrelationships among oxidative stress, niacin response, cognition, and symptoms in chronic schizophrenia: a case-control study.BMC psychiatry · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSchizophrenia is a debilitating mental disorder linked to oxidative stress (OS) and inflammatory dysregulation. Emerging evidence suggests impaired niacin sensitivity in schizophrenia patients, potentially reflecting OS and inflammation. This study examined the relationships between OS markers and niacin sensitivity in male chronic schizophrenia patients to explore potential pathophysiological mechanisms and identify associated biomarkers.
methodsThe cohort of this cross-sectional study included 80 male chronic schizophrenia patients and 40 matched healthy controls. Blood samples were collected for analysis of nitric oxide (NO), total nitric oxide synthase (TNOS), inducible nitric oxide synthase (iNOS), constitutive nitric oxide synthase (cNOS), total antioxidant capacity (TAC), and vitamin E (VE). Skin niacin sensitivity was assessed via the erythema response to topical niacin. Clinical symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS). Statistical analyses (t-tests, analysis of variance, and logistic regression) were conducted to identify associations.
resultsTNOS, iNOS, cNOS, TAC, and VE levels were significantly lower in the patient group than the healthy control group (p < 0.001). Reduced skin erythema response in patients (p < 0.001) was correlated with lower TAC activity and VE levels. Plasma NO levels were positively correlated with PANSS positive symptom scores (r = 0.370, p = 0.004). TAC was a significant protective predictor of an impaired niacin response (OR = 0.990, p = 0.001).
conclusionChronic schizophrenia is associated with disrupted redox balance and reduced niacin sensitivity, suggesting an interplay between the oxidative and inflammatory pathways. A weakened niacin response, related to antioxidant deficits, may be linked to the severity of OS. These findings highlight the importance of further research into antioxidant pathways. Additional longitudinal studies are warranted to clarify the nature of these relationships and their clinical relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.